Goldman Sachs’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106M Sell
395,998
-199,506
-34% -$54M 0.01% 990
2025
Q4
$149M Buy
595,504
+173,356
+41% +$46M 0.02% 764
2025
Q3
$121M Buy
422,148
+21,270
+5% +$5.7M 0.01% 823
2025
Q2
$105M Buy
400,878
+47,035
+13% +$11.5M 0.01% 865
2025
Q1
$82.4M Buy
353,843
+121,304
+52% +$29.4M 0.01% 882
2024
Q4
$53.3M Sell
232,539
-122,990
-35% -$28.2M 0.01% 1242
2024
Q3
$79.5M Buy
+355,529
New +$78.1M 0.01% 924
2024
Q2
Sell
-323,074
Closed -$70.6M 5813
2024
Q1
$70.6M Buy
323,074
+76,214
+31% +$16.8M 0.01% 968
2023
Q4
$56.1M Buy
246,860
+16,736
+7% +$3.52M 0.01% 1109
2023
Q3
$46.3M Sell
230,124
-297,316
-56% -$62.7M 0.01% 1147
2023
Q2
$109M Buy
527,440
+284,618
+117% +$55.2M 0.02% 672
2023
Q1
$47.9M Sell
242,822
-269,580
-53% -$55.5M 0.01% 1098
2022
Q4
$104M Sell
512,402
-90,726
-15% -$17.7M 0.03% 705
2022
Q3
$106M Buy
603,128
+78,497
+15% +$16.1M 0.03% 650
2022
Q2
$106M Buy
524,631
+182,141
+53% +$38.8M 0.03% 649
2022
Q1
$77.6M Buy
342,490
+16,536
+5% +$3.89M 0.02% 935
2021
Q4
$88M Sell
325,954
-113,093
-26% -$28M 0.02% 887
2021
Q3
$106M Buy
439,047
+194,137
+79% +$48.9M 0.02% 720
2021
Q2
$58M Buy
244,910
+6,140
+3% +$1.4M 0.01% 1123
2021
Q1
$52.3M Buy
238,770
+30,400
+15% +$6.1M 0.01% 1140
2020
Q4
$36.4M Sell
208,370
-283,531
-58% -$49M 0.01% 1372
2020
Q3
$79.6M Buy
491,901
+176,421
+56% +$28M 0.02% 690
2020
Q2
$45M Sell
315,480
-121,853
-28% -$16.9M 0.01% 1034
2020
Q1
$47.5M Sell
437,333
-228,853
-34% -$33M 0.02% 901
2019
Q4
$96.8M Buy
666,186
+31,247
+5% +$4.51M 0.02% 714
2019
Q3
$91.6M Sell
634,939
-175,249
-22% -$25.6M 0.03% 711
2019
Q2
$120M Sell
810,188
-120,954
-13% -$16.9M 0.03% 570
2019
Q1
$122M Sell
931,142
-131,401
-12% -$16.2M 0.04% 551
2018
Q4
$115M Sell
1,062,543
-225,992
-18% -$30.3M 0.04% 549
2018
Q3
$192M Buy
1,288,535
+218,149
+20% +$33.2M 0.05% 429
2018
Q2
$165M Sell
1,070,386
-830,413
-44% -$125M 0.04% 488
2018
Q1
$264M Sell
1,900,799
-310,759
-14% -$45.6M 0.07% 313
2017
Q4
$303M Buy
2,211,558
+313,285
+17% +$41.4M 0.07% 294
2017
Q3
$246M Buy
1,898,273
+91,874
+5% +$12.3M 0.06% 344
2017
Q2
$239M Sell
1,806,399
-161,526
-8% -$19.8M 0.06% 333
2017
Q1
$243M Buy
1,967,925
+73,487
+4% +$8.7M 0.07% 308
2016
Q4
$209M Sell
1,894,438
-266,825
-12% -$29.6M 0.06% 378
2016
Q3
$255M Sell
2,161,263
-674,783
-24% -$79.5M 0.08% 250
2016
Q2
$317M Sell
2,836,046
-246,885
-8% -$26.6M 0.1% 176
2016
Q1
$310M Sell
3,082,931
-234,628
-7% -$22.5M 0.1% 187
2015
Q4
$352M Buy
3,317,559
+397,424
+14% +$41M 0.11% 178
2015
Q3
$272M Buy
2,920,135
+65,367
+2% +$6.76M 0.09% 208
2015
Q2
$297M Sell
2,854,768
-4,891
-0.2% -$509K 0.09% 223
2015
Q1
$310M Sell
2,859,659
-125,250
-4% -$12.9M 0.1% 208
2014
Q4
$277M Buy
2,984,909
+986,072
+49% +$87.1M 0.09% 243
2014
Q3
$175M Sell
1,998,837
-34,267
-2% -$3.1M 0.06% 379
2014
Q2
$179M Buy
2,033,104
+98,726
+5% +$8.55M 0.06% 402
2014
Q1
$163M Buy
1,934,378
+497,281
+35% +$39.7M 0.05% 396
2013
Q4
$113M Buy
1,437,097
+1,140,225
+384% +$97.3M 0.04% 579
2013
Q3
$25.3M Sell
296,872
-119,464
-29% -$10.1M 0.01% 1425
2013
Q2
$35.8M Buy
+416,336
New +$34.6M 0.01% 1113

Other funds holding LH

Goldman Sachs's LH Position: Q1 2026 in Review

Goldman Sachs reduced its Labcorp (LH) stake by 34% in Q1 2026, selling an estimated $54M and leaving 395,998 shares worth $106M. The position accounts for 0.01% of the portfolio, ranked #990.

Goldman Sachs first reported a position in LH in Q2 2013 and has held it in 51 quarters since. The position peaked at $352M in Q4 2015. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Goldman Sachs held 395,998 shares of Labcorp worth $106M as of Q1 2026.
  • Goldman Sachs sold 199,506 Labcorp shares in Q1 2026, an estimated $54M.
  • Labcorp made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #990 holding.
  • Goldman Sachs first reported a position in Labcorp in Q2 2013 and has held it in 51 quarters since.
  • Goldman Sachs's Labcorp position peaked at $352M in Q4 2015.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.